Annual report
4563.TEDINET S100XTMQ
Period2025-01-01 → 2025-12-31
Filed2026-03-25
StandardJapan GAAP
ConsolidatedYes
Data checks20 of 20 passed
Key figures · 125
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Operating income | −¥5.1bn | 2025-01-01 → 2025-12-31 | Cons. | Operating income |
| Operating income | −¥9.1bn | 2024-01-01 → 2024-12-31 | Cons. | Operating income |
| Ordinary income | −¥5.3bn | 2025-01-01 → 2025-12-31 | Cons. | Ordinary income |
| Ordinary income | −¥7.5bn | 2024-01-01 → 2024-12-31 | Cons. | Ordinary income |
| Ordinary income | −¥5.7bn | 2023-01-01 → 2023-12-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥14.6bn | 2022-01-01 → 2022-12-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥13.6bn | 2021-01-01 → 2021-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | −¥5.2bn | 2025-01-01 → 2025-12-31 | Cons. | Income before income taxes |
| Profit before tax | −¥27.6bn | 2024-01-01 → 2024-12-31 | Cons. | Income before income taxes |
| Net income (owners) | −¥5.1bn | 2025-01-01 → 2025-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥28.1bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥7.4bn | 2023-01-01 → 2023-12-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥14.7bn | 2022-01-01 → 2022-12-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥13.7bn | 2021-01-01 → 2021-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | −¥5.1bn | 2025-01-01 → 2025-12-31 | Cons. | Profit loss |
| Net income | −¥28.1bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss |
| Total assets | ¥5.4bn | at 2025-12-31 | Cons. | Assets |
| Total assets | ¥4.7bn | at 2024-12-31 | Cons. | Assets |
| Total assets | ¥28.9bn | at 2023-12-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥38.8bn | at 2022-12-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥45.5bn | at 2021-12-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥2.3bn | at 2025-12-31 | Cons. | Liabilities |
| Total liabilities | ¥2.5bn | at 2024-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥3.1bn | at 2025-12-31 | Cons. | Net assets |
| Net assets / equity | ¥2.2bn | at 2024-12-31 | Cons. | Net assets |
| Net assets / equity | ¥26.1bn | at 2023-12-31v | Cons. | Net assets |
| Net assets / equity | ¥30.4bn | at 2022-12-31v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥38.6bn | at 2021-12-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.9bn | at 2025-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.7bn | at 2024-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.8bn | at 2025-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.6bn | at 2024-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.1bn | at 2023-12-31v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥11.0bn | at 2022-12-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥17.8bn | at 2021-12-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | −¥5.8bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥6.6bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥8.7bn | 2023-01-01 → 2023-12-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥11.2bn | 2022-01-01 → 2022-12-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥11.4bn | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | ¥19m | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥131m | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥357m | 2023-01-01 → 2023-12-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥97m | 2022-01-01 → 2022-12-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥155m | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥5.9bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥4.2bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥2.0bn | 2023-01-01 → 2023-12-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥3.6bn | 2022-01-01 → 2022-12-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥17.4bn | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥-14.44 | 2025-01-01 → 2025-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-119.53 | 2024-01-01 → 2024-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-39.29 | 2023-01-01 → 2023-12-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-94.29 | 2022-01-01 → 2022-12-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-92.86 | 2021-01-01 → 2021-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥7.67 | at 2025-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥7.17 | at 2024-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥131.04 | at 2023-12-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥169.77 | at 2022-12-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥251.81 | at 2021-12-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 55.2% | at 2025-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 44.0% | at 2024-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 90.0% | at 2023-12-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.1% | at 2022-12-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 84.8% | at 2021-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| Employees | 56 | at 2025-12-31 | Cons. | Number of employees |
| Employees | 55 | at 2024-12-31 | Cons. | Number of employees |
| Employees | 145 | at 2023-12-31v | Cons. | Number of employees |
| Employees | 138 | at 2022-12-31v | Cons. | Number of employees |
| Employees | 131 | at 2021-12-31d | Cons. | Number of employees |
| Operating income | −¥4.4bn | 2025-01-01 → 2025-12-31 | Standalone | Operating income |
| Operating income | −¥4.9bn | 2024-01-01 → 2024-12-31 | Standalone | Operating income |
| Ordinary income | −¥4.5bn | 2025-01-01 → 2025-12-31 | Standalone | Ordinary income |
| Ordinary income | −¥3.1bn | 2024-01-01 → 2024-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥2.0bn | 2023-01-01 → 2023-12-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥8.0bn | 2022-01-01 → 2022-12-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥7.9bn | 2021-01-01 → 2021-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | −¥5.7bn | 2025-01-01 → 2025-12-31 | Standalone | Income before income taxes |
| Profit before tax | −¥39.3bn | 2024-01-01 → 2024-12-31 | Standalone | Income before income taxes |
| Net income | −¥5.7bn | 2025-01-01 → 2025-12-31 | Standalone | Profit loss |
| Net income | −¥39.3bn | 2024-01-01 → 2024-12-31 | Standalone | Profit loss |
| Net income | ¥1.1bn | 2023-01-01 → 2023-12-31v | Standalone | Net income loss (5-year summary) |
| Net income | −¥8.1bn | 2022-01-01 → 2022-12-31v | Standalone | Net income loss (5-year summary) |
| Net income | −¥8.1bn | 2021-01-01 → 2021-12-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥4.4bn | at 2025-12-31 | Standalone | Assets |
| Total assets | ¥3.7bn | at 2024-12-31 | Standalone | Assets |
| Total assets | ¥38.7bn | at 2023-12-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥40.7bn | at 2022-12-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥44.9bn | at 2021-12-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥1.8bn | at 2025-12-31 | Standalone | Liabilities |
| Total liabilities | ¥1.3bn | at 2024-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥2.7bn | at 2025-12-31 | Standalone | Net assets |
| Net assets / equity | ¥2.4bn | at 2024-12-31 | Standalone | Net assets |
| Net assets / equity | ¥37.3bn | at 2023-12-31v | Standalone | Net assets |
| Net assets / equity | ¥34.1bn | at 2022-12-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥38.7bn | at 2021-12-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥1.2bn | at 2025-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.1bn | at 2024-12-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥-15.95 | 2025-01-01 → 2025-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-167.03 | 2024-01-01 → 2024-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥5.64 | 2023-01-01 → 2023-12-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-52 | 2022-01-01 → 2022-12-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-54.91 | 2021-01-01 → 2021-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥5.49 | 2023-01-01 → 2023-12-31v | Standalone | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥6.62 | at 2025-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥8.03 | at 2024-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥187.33 | at 2023-12-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥190.57 | at 2022-12-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥252.16 | at 2021-12-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 58.2% | at 2025-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 61.4% | at 2024-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 96.1% | at 2023-12-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 83.6% | at 2022-12-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 86.0% | at 2021-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 3.0% | 2023-01-01 → 2023-12-31v | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 389,026,550 | at 2025-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 286,377,550 | at 2024-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 198,470,300 | at 2023-12-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 178,623,900 | at 2022-12-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 153,072,400 | at 2021-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 35 | at 2025-12-31 | Standalone | Number of employees |
| Employees | 33 | at 2024-12-31 | Standalone | Number of employees |
| Employees | 40 | at 2023-12-31v | Standalone | Number of employees |
| Employees | 39 | at 2022-12-31v | Standalone | Number of employees |
| Employees | 42 | at 2021-12-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 2
| Segment | Item | Period | Value |
|---|---|---|---|
| Pharmaceutical Businessreportable segment | employees | at 2025-12-31 | 56 pure |
| Pharmaceutical Businessreportable segment | employees | at 2025-12-31 | 35 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,378
| Item | Context | Value | Unit |
|---|---|---|---|
| Consolidated statement of changes in equity (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of cash flows (text) | CurrentYearDuration | Text · Plus | |
| Notes uncertainties of entitys ability to continue as going concern consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes significant accounting policies for preparation of consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Number of consolidated subsidiaries and names of major consolidated subsidiaries (text) | CurrentYearDuration | Text · Plus | |
| Number of unconsolidated subsidiaries and associates accounted for using equity method and names of major entities accounted for using equity method (text) | CurrentYearDuration | Text · Plus | |
| Names of major unconsolidated subsidiaries and associates and reasons for not being accounted for using equity method (text) | CurrentYearDuration | Text · Plus | |
| Disclosure about fiscal years etc of consolidated subsidiaries (text) | CurrentYearDuration | Text · Plus | |
| Disclosure of accounting policies (text) | CurrentYearDuration | Text · Plus | |
| Significant accounting estimates consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes new accounting standards not yet applied consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding amounts of notes and accounts receivable trade and contract assets (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding shares and bonds etc of unconsolidated subsidiaries and associates (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding gross income the amount of revenue deducted (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding write downs of inventories (text) | CurrentYearDuration | Text · Plus | |
| Research and development expenses included in general and administrative expenses and manufacturing cost for current period (text) | CurrentYearDuration | Text · Plus | |
| Major components of selling general and administrative expenses (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding gain on sales of property plant and equipment (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding impairment loss (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding business structual reform expenses text block (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding reclassification adjustments income taxes and tax effects relating to other comprehensive income (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding issued shares and treasury shares (text) | Prior1YearDuration | Text · Plus | |
| Notes regarding new share subscription rights etc (text) | Prior1YearDuration | Text · Plus | |
| Notes regarding issued shares and treasury shares (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding new share subscription rights etc (text) | CurrentYearDuration | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | CurrentYearDuration | Text · Plus | |
| Description of significant transactions not requiring use of cash or cash equivalents (text) | CurrentYearDuration | Text · Plus | |
| Notes leases consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes financial instruments consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes securities consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes share options etc consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes tax effect accounting consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes asset retirement obligations consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes revenue recognition consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes segment information etc consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Description of fact that companys business comprises single segment | CurrentYearDuration | Text · Plus | |
| Information for each product or service (text) | Prior1YearDuration | Text · Plus | |
| Revenues from external customers information for each region (text) | Prior1YearDuration | Text · Plus | |
| Property plant and equipment information for each region (text) | Prior1YearDuration | Text · Plus | |
| Information for each of main customers (text) | Prior1YearDuration | Text · Plus | |
| Information for each product or service (text) | CurrentYearDuration | Text · Plus | |
| Revenues from external customers information for each region (text) | CurrentYearDuration | Text · Plus | |
| Property plant and equipment information for each region (text) | CurrentYearDuration | Text · Plus | |
| Information for each of main customers (text) | CurrentYearDuration | Text · Plus | |
| Description of factors which led to recognition of gain on bargain purchase (text) | CurrentYearDuration | Text · Plus | |
| Notes related parties consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes per share information consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes significant events after reporting period consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Annexed consolidated detailed schedule of corporate bonds (text) | CurrentYearDuration | Text · Plus | |
| Annexed consolidated detailed schedule of borrowings (text) | CurrentYearDuration | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 20 of 20 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |